 |
       
|
Provenge Now is a patient advocate initiative created to gain immediate FDA approval for the first-ever Active Cellular Immunotherapy treatment for prostate cancer. Survivors hope to extend their lives with a better quality with this new type of landmark treatment. Provenge is a symbol for a new era in prostate cancer treatment. Patient advocates do not dispute FDA's request for more clinical data. Our position is that this confirmatory data should be a requirement post approval and that Provenge should be approved now by the FDA for patient use. The Provenge Now advocate organizations support immediate approval of new prostate cancer treatments to expand the options available to patients, including Active Cellular Immunotherapies. |
|
  Click to take action.
 Click to take action.
THE FDA HAS OPTIONS
The FDA had, and still has, options for approving Provenge now and obtaining additional data to continue evaluating this treatment... FDA criticized for delay in prostate cancer drug Philadelphia Inquirer news story.. BLACK WEDNESDAY AT THE FDA - Wall Street Journal ABC news June 4 ABC TV news story... DID THE FDA TURN ITS BACK ON BLACK MEN... Black men in the U. S. suffer a prostate cancer mortality rate 140% higher than for all other men.. HONORING BLACK MEN WITH GOOD SCIENCE Dr. Mary S. Harris, Journey to Wellness, views on "Did The FDA Turn Its Back On Black Men" HONORING BLACK MEN THROUGH GOOD JUDGMENTS Why Wait For A New Prostate Cancer Treatment In The Face Of An Epidemic? DR. MARK MOYAD SPEAKS AT PROVENGENOW RALLY June 4th ProvengeNow Rally NEW STUDY SUPPORTS PROSTATE CANCER VACCINES A National Institute of Health study comments on provenge and others..  |
